NEW YORK, June 27 (GenomeWeb News) - Cyntellect will receive approximately $500,000 from the National Science Foundation to continue developing its LEAP (laser-enabled analysis and processing) transfection system for RNAi applications, the company said today.
The company said it will use the Phase IIB Small Business Innovative Research grant to enable "high-efficiency, low-toxicity delivery of siRNA into cells that are typically refractory to standard transfection techniques."
NSF's Phase IIB SBIR program provides matching funds up to $500,000 to companies that meet the goals of a Phase II grant and are also able to secure additional investment from non-governmental sources.